ArticleOncotarget2018

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8

Francois Desgrandchamps et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.